Gene-screen strategy separates Parkinson's promoters from protectors, revealing new drug targets

A novel strategy that combines computational and experimental approaches has allowed researchers at Baylor College of Medicine and the Duncan Neurological Research Institute (Duncan NRI) at Texas Children's Hospital to distinguish alterations in gene function that contribute to Parkinson's disease f